Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 27;139(38):13562-13569.
doi: 10.1021/jacs.7b07792. Epub 2017 Sep 18.

Enantiospecific Solvolytic Functionalization of Bromochlorides

Affiliations

Enantiospecific Solvolytic Functionalization of Bromochlorides

Alexander J Burckle et al. J Am Chem Soc. .

Abstract

Herein, we report that under mild solvolytic conditions, enantioenriched bromochlorides can be ionized, stereospecifically cyclized to an array of complex bromocyclic scaffolds, or intermolecularly trapped by exogenous nucleophiles. Mechanistic investigations support an ionic mechanism wherein the bromochloride serves as an enantioenriched bromonium surrogate. Several natural product-relevant motifs are accessed in enantioenriched form for the first time with high levels of stereocontrol, and this technology is applied to the scalable synthesis of a polycyclic brominated natural product. Arrays of nucleophiles including olefins, alkynes, heterocycles, and epoxides are competent traps in the bromonium-induced cyclizations, leading to the formation of enantioenriched mono-, bi-, and tricyclic products. This strategy is further amenable to intermolecular coupling between cinnamyl bromochlorides and a diverse set of commercially available nucleophiles. Collectively, this work demonstrates that enantioenriched bromonium chlorides are configurationally stable under solvolytic conditions in the presence of a variety of functional groups.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Representative bromocyclic natural products. (B) Putative biosynthetic pathway for the biosynthesis of two related natural products involving several discrete bromocyclization steps. (C) Our previous work on a stereospecific bromopolyene cyclization and that accomplished in this report.
Figure 2
Figure 2
Computational investigation of the interconversion of bromochloride constitutional isomers at the M06-2X/6-31G+(d) level of theory; uncorrected electronic energies are listed in kcal/mol (PCM = polarizable continuum model).
Scheme 1
Scheme 1
Solvolytic epoxide opening cascade for the synthesis of a brominated pyrana aReagents and conditions: (i) K2CO3 (1.5 equiv), 1,1,1,3,3,3-hexafluoroisopropanol (0.05 M), rt; (ii) HCl (concentrated aq., 5 equiv), wet Et2O, rt, 34% over two steps.
Scheme 2
Scheme 2
Application of the dihalide solvolysis to a scalable, enantioselective synthesis of a brominated natural producta aReagents and conditions: (a) K2CO3 (1.5 equiv), 1,1,1,3,3,3-hexafluoroisopropanol (0.05 M), rt; (b) trifluoroacetic acid, CH2Cl2, rt; PhMe, 110 °C, 75% over two steps; (c) trimethylaluminum (3.0 equiv), N,O-dimethylhydroxylamine hydrochloride (3.0 equiv), CH2Cl2, 0 °C to rt; (d) methyllithium lithium bromide complex (3.5 equiv), THF, −78 °C; (e) vinylmagnesium chloride, Et2O, 0 °C, 73% over two steps; (f) BF3· OEt2 (1.5 equiv), CH2Cl2, 4 °C, 50% (6:1 dr).

References

    1. Gribble GW. Naturally Occurring Organohalogen Compounds – A Comprehensive Survey. Springer-Verlag; Wien: 1996. - PubMed
    2. Gribble GW. Naturally Occurring Organohalogen Compounds – A Comprehensive Update. Springer-Verlag; Wien: 2010.
    3. Wang BG, Gloer JB, Ji NY, Zhao JC. Chem. Rev. 2013;113:3632–3685. - PubMed
    4. Brito I, Dias T, Diaz-Marrero AR, Darias J, Cueto M. Tetrahedron. 2006;62:9655–9660.
    5. Brito I, Dias T, Diaz-Marrero AR, Darias J, Cueto M. Tetrahedron. 2007;63:3908.
    1. Federov SN, Reshetnyak AP, Shchedrin AP, Il’in SG, Struchkov YT, Stonik VA, Elyakov GB. Dokl. Akad. Nauk SSSR. 1989;305:877–879.
    2. Lyakhova EG, Federov SN, Shubina LK, Radchenko OS, Kalinovsky AI, Dvitrenok PS, Stonki VA. Russ. Chem. Bull. Int. Ed. 2003;52:970–974.
    3. Federov SN, Shubina LK, Bode AM, Stonik VA, Dong Z. Cancer Res. 2007;67:5194–5920. - PubMed
    1. Lane AL, Stout EP, Hay ME, Prusak AC, Hardcastle K, Fairchild CR, Franzblau SG, Le Roch K, Prudhomme J, Aalbersberg W, Kubanek J. J. Org. Chem. 2007;72:7343–7351. - PMC - PubMed
    1. Suzuki T, Suzuki M, Furusaki A, Matsumoto T, Kato A, Imanaka Y, Kurosawa E. Tetrahedron Lett. 1985;26:1329–1332.
    2. Suzuki T, Takeda S, Suzuki M, Kurosawa E, Kato A, Imanaka Y. Chem. Lett. 1987:361–364.
    1. Carter-Franklin JN, Butler AJ. J. Am. Chem. Soc. 2004;126:15060–15066. - PubMed
    2. Fukuzawa A, Miyamoto M, Kumagai Y, Abiko A, Takaya Y, Masamune T. Chem. Lett. 1985:1259–1262.
    3. Findlay JA, Li G. Can. J. Chem. 2002;80:1697–1707.

Publication types

LinkOut - more resources